Last checked at 8 Nov 2017 15:03
SUPPLEMENTAL FORM 8
DETAILS OF AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: | Universities Superannuation Scheme Ltd |
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: | Spire Healthcare Group PLC |
2. STOCKS
Class of relevant security | Product description e.g. call option | Written or purchased | Number of securities sold | price per unit | Type e.g. American, European etc. | Expiry date |
Equities | Sell |
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood: |
USSIM traded on GB00BNLPYF73, a sell trade of 500,000.00, but only 5,845.00 of the 500,000.00 order was filled yesterday. Our total holding is currently at 4,496,842.00.
|
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.